AstraZeneca Sees China As An Opportunity To Innovate Differently
This article was originally published in PharmAsia News
Executive Summary
China offers vast opportunities for international drug makers, says AstraZeneca’s R&D chief in Asia, leading the British firm to expand operations there in all aspects of its business.